Baraliakos, Xenofon;
Boteva, Boryana;
Bremander, Ann;
Carron, Philippe;
Ciurea, Adrian;
Hooge, Manouk de;
van der Heijde, Désirée;
Gensler, Lianne;
van Gaalen, Floris A;
Géher, Pál;
Hermann, Josef;
Husakova, Marketa;
Kiltz, Uta;
Landewé, Robert B M;
López-Medina, Clementina;
Machado, Pedro M;
Marzo-Ortega, Helena;
Molto, Anna;
Navarro-Compán, Victoria;
Nikiphorou, Elena;
Nissen, Michael J;
Ortolan, Augusta;
Pimentel-Santos, Fernando M;
Poddubnyy, Denis;
Proft, Fabian;
Ramiro, Sofia;
Rudwaleit, Martin;
Sepriano, Alexandre;
Telkman, Mark;
Van den Bosch, Filip E;
Webers, Casper;
Zhao, Sizheng Steven;
Ziade, Nelly.
To update the Assessment of
SpondyloArthritis international Society (ASAS)-EULAR
recommendations for the management of axial
spondyloarthritis (axSpA).
Following the EULAR Standardised Operating
Procedures, two systematic literature reviews were
conducted on non-pharmacological and pharmacological
treatm...
Fraenkel, Liana;
Bathon, Joan;
England, Bryant;
St Clair, William;
Arayssi, Thurayya;
Carandang, Kristine;
Deane, Kevin;
Genovese, Mark;
Huston, Kent;
Kerr, Gail;
Akl, Elie;
Turner, Amy.
To develop updated guidelines for the pharmacologic management of rheumatoid arthritis. We developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions. After conducting a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluat...
Inflammatory joint diseases are a group of diseases characterized by autoimmune inflammation in the joints and sometimes in other tissues and organs. The most common inflammatory joint diseases are rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) and spondyloarthritis (SpA). Spondyloarthrit...
Lau, Chak Sing;
Chia, Faith;
Dans, Leonila;
Harrison, Andrew;
Hsieh, Tsu Yi;
Jain, Rahul;
Jung, Seung Min;
Kishimoto, Mitsumasa;
Kumar, Ashok;
Leong, Khai Pang;
Li, Zhanguo;
Lichauco, Juan Javier;
Louthrenoo, Worawit;
Luo, Shue Fen;
Mu, Rong;
Nash, Peter;
Ng, Chin Teck;
Suryana, Bagus;
Wijaya, Linda Kurniaty;
Yeap, Swan Sim.
To update recommendations based on current best evidence concerning the treatment of rheumatoid arthritis (RA), focusing particularly on the role of targeted therapies, to inform clinicians on new developments that will impact their current practice. A search of relevant literature from 2014 to 2016 conc...
Goodman, SM;
Springer, B;
Guyatt, G;
Abdel, MP;
Dasa, V;
George, M;
Gewurz-Singer, O;
Giles, JT;
Johnson, B;
Lee, S;
Mandl, LA;
Mont, MA;
Sculco, P;
Sporer, S;
Stryker, L;
Turgunbaev, M;
Brause, B;
Chen, AF;
Gililland, J;
Goodman, M;
Hurley-Rosenblatt, A;
Kirou, K;
Losina, E;
MacKenzie, R;
Michaud, K;
Mikuls, T;
Russell, L;
Sah, A;
Miller, AS;
Singh, JA;
Yates, A.
OBJECTIVE: This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) includin...
This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthca...
Ward, M. M;
Deodhar, A;
Akl, E. A;
Lui, A;
Ermann, J;
Gensler, L. S;
Smith, J. A;
Borenstein, D;
Hiratzka, J;
Weiss, P. F;
Inman, R. D;
Majithia, V;
Haroon, N;
Maksymowych, W. P;
Joyce, J;
Clark, B. M;
Colbert, R. A;
Figgie, M. P;
Hallegua, D. S;
Prete, P. E;
Rosenbaum, J. T;
Stebulis, J. A;
Bosch, F van den;
Yu, D. T;
Miller, A. S;
Reveille, J. D;
Caplan, L.
OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conduct...
Pelvispondylite rhumatismale/traitement médicamenteux,
Spondylarthrite/traitement médicamenteux,
Anti-inflammatoires non stéroïdiens/usage thérapeutique,
Antirhumatismaux/usage thérapeutique,
Glucocorticoïdes/usage thérapeutique,
Facteur de nécrose tumorale alpha/usage thérapeutique,
Infliximab/usage thérapeutique,
Adalimumab/usage thérapeutique,
Étanercept/usage thérapeutique,
Techniques de physiothérapie,
Pelvispondylite rhumatismale/thérapie
Singh, JA;
Saag, KG;
Bridges Jr, SL;
Akl, EA;
Bannuru, RR;
Sullivan, MC;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, RH;
Curtis, JR;
Furst, DE;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, EL;
Schousboe, JT;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, EW;
Tindall, E;
Miller, AS;
McAlindon, T.
OBJECTIVE:
To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).
METHODS:
We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eva...
Singh, JA;
Saag, KG;
Bridges SL, Jr;
Akl, EA;
Bannuru, RR;
Sullivan, MC;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, RH;
Curtis, JR;
Furst, DE;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, EL;
Schousboe, JT;
Drevlow, B;
Ginsberg, S;
Grober, J;
St, Clair, EW;
Tindall, E;
Miller, AS;
McAlindon, T.
"OBJECTIVE:
To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).
METHODS:
We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Ev...
Singh, J. A;
Saag, K. G;
Bridges Junior, S. L;
Akl, E. A;
Bannuru, R. R;
Sullivan, M. C;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, R. H;
Curtis, J. R;
Furst, D. E;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, E. L;
Schousboe, J. T;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, E. W;
Tindall, E;
Miller, A. S;
McAlindon, T.
OBJECTIVE: To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA). METHODS: We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eval...